Alliance Entertainment Holding Corporation (AENT)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	264	153	129	142	140	-
Market Cap Growth	56.62%	18.46%	-9.42%	1.75%	-	-
Enterprise Value	365	249	272	146	-	-
Last Close Price	5.19	3.00	2.55	9.89	9.72	-
PE Ratio	22.58	33.30	-	4.97	4.09	-
PS Ratio	0.25	0.14	0.11	0.10	0.11	-
PB Ratio	2.72	1.74	1.62	1.31	1.74	-
P/TBV Ratio	-	-	-	13.86	-	-
P/FCF Ratio	14.58	2.74	50.25	-	1.89	-
P/OCF Ratio	10.28	2.74	38.01	-	1.87	-
EV/Sales Ratio	0.34	0.23	0.24	0.10	-	-
EV/EBITDA Ratio	13.78	11.12	-	2.44	-	-
EV/EBIT Ratio	17.22	15.07	-	2.83	-	-
EV/FCF Ratio	20.11	4.48	106.21	-	-	-
Debt / Equity Ratio	1.05	1.25	1.87	1.37	0.90	1.17
Debt / EBITDA Ratio	3.25	3.85	-	2.21	0.97	1.64
Debt / FCF Ratio	5.64	1.98	58.01	-	0.97	2.50
Asset Turnover	3.19	3.01	2.69	3.29	3.98	-
Inventory Turnover	9.32	7.89	5.27	6.25	11.04	-
Quick Ratio	0.63	0.63	0.35	0.29	0.49	0.45
Current Ratio	1.30	1.33	0.87	1.02	1.11	0.89
Return on Equity (ROE)	12.96%	5.48%	-37.57%	30.25%	51.31%	-
Return on Assets (ROA)	3.93%	2.83%	-3.56%	7.51%	10.68%	-
Return on Capital (ROIC)	6.91%	4.86%	-6.33%	15.78%	26.64%	-
Return on Capital Employed (ROCE)	10.90%	8.60%	-	42.30%	37.80%	15.30%
Earnings Yield	4.47%	3.00%	-27.49%	20.13%	24.46%	-
FCF Yield	6.86%	36.44%	1.99%	-58.81%	53.01%	-
Payout Ratio	-	-	-	-	19.93%	-
Buyback Yield / Dilution	-1.18%	-5.61%	-1.34%	-5177.78%	-	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q